Legal notice
Legal and publishing information for axelyumhealth.com.
1. Website publisher
- Company
- AXELYUM MEDTECH SASU — French single-shareholder simplified joint-stock company
- Share capital
- EUR 4,500
- Registered office
- Les Aqueducs – Bâtiment 3, 535 Route des Lucioles, 06560 Valbonne, France
- Registration
- SIREN 105 779 011 · SIRET 105 779 011 00011 · RCS Grasse 105 779 011 · APE 72.19Z
- VAT number
- FR90105779011
- Contact
- luc.pichotte@axelyumhealth.com
2. Publication director
Luc Pichotte, President of AXELYUM MEDTECH SASU.
3. Hosting provider
HOSTINGER INTERNATIONAL LIMITED, 61 Lordou Vironos Street, 6023 Larnaca, Cyprus. Website: www.hostinger.com. Entity code CY10301365E.
4. Website purpose
Corporate presentation of an R&D company and medical technology under investigation. Intended mainly for professional, industrial and institutional audiences. It neither sells a medical device nor provides clinical instructions.
5. Intellectual property
Unless stated otherwise, texts, brands, original graphics and illustrations are used by AXELYUM MEDTECH under its respective rights. Three French patent applications have been filed for the PERFU+3 project. Filing is not the same as patent grant. Access to the website conveys no licence or exploitation right.
6. Medical, regulatory and operational disclaimers
PERFU+3 is a technology under development. No validated integrated prototype, guaranteed performance, CE marking, clinical authorisation or commercial availability is claimed. Emergency, transport, defence and operational-health contexts are potential applications to be evaluated, not evidence of qualification, procurement or institutional endorsement.
7. Liability
Website content is indicative and may evolve as engineering and testing progress. AXELYUM MEDTECH may correct or remove content without advance notice. Content is neither medical nor regulatory advice.
8. Personal data
Please refer to the privacy policy for professional enquiries and hosting-related technical data.
9. Applicable law
French law applies, subject to mandatory European Union law.
Updated: 9 November 2026. Legal review is recommended before publication.
